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06jectivcs. The aim of this study was to determine whether 
esmold, an ulIr&ort-acting betvadrcnrrgir antagonist. pew 
sesws. cardiaprotective properlies unrelated to a wncomitant 
dew&e in heart rate. 
Background. Prw/ous studies have demonstrated beneficial 
rlfects of beta-adrettergic bl&ciing agents with unchanged heart 
rates. 
Melhcds. The effect of e;molol (100 &~/kg per minj on the 
response of global cardiorm~&r and regional mywcardiai con- 
tractile function (saaomi~~metry) tc padnginduced tarhycardia 
and acute left ventrirular afterloading wg arsesjed in dogs wilh a 
crilical stenosis of the left anterior desceadiug coronary artery 
(LAD). The%? responses were d~rcrwd at the baseline hemcglglobin 
level (12.5 t 0.3 @Xl ml) as pea SLY after hemodilution-induced 
mild regional mntractile dysfunc!iw (7.4 + 0.4 gilO0 ml) in the 
area SupPUd by thls artery (LAD arfa). Data were analyzed by 
In a variety of clinical settings and e~.perimental models of 
myocardial ischemia, beta-adrenergic antagonists have been 
shown to exert a ben&zial effect or ischemic or coronary 
flow-wmproroked myocardium. Thz beneficial effect was 
charackized by amelioration of ischemh-related electro- 
cardiographic (ECG) changes (1.2). preservation of high 
energy phosphates (31, reduced infarct size (4-6). decreased 
infarct-related mortality (7). improvement of regional tnyo- 
cardial function (2,4,8-N& and higher p,lcing rate tolerated 
by patients with coronary artery diseass ;;!). These beta- 
adrenergic antagonist-related beneficial effects on ixhemic 
or coronary flew-compromised myocardium may be viewed 
as cardioprotective because amelioration of ischemia or n 
reduction in infarct size may protect or preserve ischemic 
myocardium from infarction, The mechanisms by which 
beta-adrenergic mtagonists are thought to exert their bene- 
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ficial effect on ischemic or coronary flow-compromised 
myocardium are a decrease in heart rate and conlraclility 
with a concomitant reduction of myocardial oxygen con- 
sumption ~?.4+10.12.13). a redistribution of (compromiscdl 
coronary blood flow in favor of the kchemic myocardittm (2) 
(in particular in favor of the subertdocardium [l.lY), a 
decrease in sympathelic tone (15). an alteration in myocar- 
dial substrxe utilization (16) and a stabilization of cell 
membranes ( 17). 
Esmoljl is an ultrashort-acting. card&elective beta- 
adrenergic antagonist tZat may be preferable to use in 
critically ill patients or in patients with limited cardiac 
reserve. because. should adverse effects occur. they are 
short-lived. Esmolol has been shown !o reduce infarct size 
(3.6) and to improve regional myocardial function during 
reperfision in canine models of coronary artery occlusion 
(IQ. However, heart rate was significantly lower during the 
estnolol infusion in two of these studies (4,10X thus. it is 
unclear whether the observed cardioprotectionrepresents an 
intrinsic esmolol effect, that is. unrelated to the alteration in 
heart rate. or whether these findings resulted from an es- 
molol-induced decrease in heart mte. Previous studies have 
demonstrat-d beneficial effects of beta-adrenergic antago- 
nists with unchanged heart rates, suggesting an inVinsic drug 
effect(l.3.5,6,8,9,ll,ig,l9~. Wethereforetested the hypoth- 
esis that csmolo! hss intrinsic cardioprotective properties. 
unrelated to slowing of heart rate, beneficial for coronary 
flow.-compromised myocardium. We tested this hypothesis 
by observing the responses of global cardiovascular and 
regional myocardial contractile functions to increasing atrial 
pacing rates and to abruptly increasing left ventricular 
aftcrlaad in a canine model of acute. critical coronary 
stenosis. These hemodynamic stresses were performed at 
the baseline hemoglobin level and, to induce further exag- 
gerated imbalance between myocardial oxygen consumption 
and compromised oxygen delivery, during normovdemic 
hemodilution resulting in a decreased arterial oxygen con- 
tent and myocardial oxygen delivery. 
Methods 
This study was approved by the lnstitlrtional Animal Care 
and Use Committee, and all animals used in these experi- 
ments received humane care in compliance with the “Prin- 
ciples of Laboratory Animal Care” formulated by the Nn- 
tional Society for Medical Research, the “C;uide for the Care 
and Use of Laboratory Animals” prepared by the National 
Academy of Science and published by the National Insti- 
tutes of Health (NIH Publication No. 80-23, revised 1978) 
and conform to the “Position of the American Heart Asso- 
ciation on Research Animal Use” adopted November II. 
1984 by the American Heatr Association. 
Instrumentation. In 20 unpremeditated dogs, weighing 
20 to 26 kg, anesthesia was intravenously induced with 
thirpental (20 to 2.5 m&g body weight). The trachea was 
intlibated and the animals were ventilnted with an air-oxygen 
mixture to normocarbia at a rate of IO breathslmin (Ohio V5 
Airco, Ohmeda) to achieve arterial oxygen partial pressures 
of lo0 to 200 mm Hg. End-tidal carbon dioxide and halo- 
thane concentrations were continuously measured by in- 
frared spectroscopy [Datex model 254, Puritan Bennett 
Corporation). To prevent deleterious hyperdynamic and 
tachycardiac responses to surgery, we used halothane 0.9% 
end-tidal anesthesia (I MAC equivalent) (20) and fentanyl 
(total loading dose of I5 &kg intravenously; infusion rate 
0.3 fig/kg per min). Fentanyl was used not only to decrease 
the sinus rate to ~90 beatsimin but also to depress the 
frequency of secondary pacemaker centers below this limit, 
as we have previously observed that such secondary pace- 
maker centers often become active with frequencies well 
above 90 beatsimin after mechanical crushing of the sinus 
node (21). 
The animals were placed in a right lateral position, and an 
intravenous caonula was introduced in the hind limb through 
which a continuous infusion of 0.9% saline solution (6 to 
8 ml/kg per h) was begun. A 7F pressure-transducer-tipped 
catheter (Millar Instruments) was inserted in the carotid 
ar!ery and advanced to the aortic root, within I cm of the 
aortic valve, to obtain aortic pressure and samples for 
arterial blood gas analyses. The heart was exposed through 
a left thoracotomy and suspended in a pericardial cradle. 
Pacing wires were attached to the right atrium, and the heart 
Figure t. Experimental preparation. Right atrial pacing was used to 
perlrrm the pacing periods, and the aortic nccluder was utilized for 
acute afterlaadingofthe left ventricle. LAD = kftanteriorderccad- 
ingcoronary artery; LCA = IeftcircumRcx coronary artery; RCA = 
right coronary artery; SMC LAD, SMC LCP and SMC LCA = 
sonomicrometer crystals. respectivsly, in the area supplied by the 
lefl anterior descending artery, and in Le basal aspect of the 
anterior left ventricular (LV) wall oupptied by the left &cum&x 
arIery, and the posterior tel7 ventricular wall, supplied by the left 
circumflex artery. 
was paced at a mte of 90 beatslmin. A 5F pressure- 
transducer-tipped catheter(Millar Instruments) was inserted 
in:o the teft ventricle via a stab incision at the apex of the 
heart to measure left ventricular pressure. The fat pad was 
dissected off the aortic root, an appropriately sized ~-MHZ 
Douuler ultrasound flow nrobe was nlaced around the aortic 
rit’and the aortic bloodflow velocity was measured with a 
Doppler flow meter (model ICO-imO5, Triton ^;2chnolo- 
gigs). A mechanical occluder was placed around the de- 
scending thoracic aorta, distal to the left subclavian artery, 
to abruptly afterload the left ventricle (see later). A proximal 
segment of the left ac!erior descending coronary artery was 
dissected free, a IO-MHz Doppler flow probe was placed 
around the artery, and blood Row velocity in the artery was 
measured with a second Doppler flow meter (model 100. 
IOW-IO, Triton Technologies). Additionally, two suture 
strings were placed around the artery: one to gradually 
constrict it with a micrometer-controlled spring-suspended 
constrictor, the second to facilitate brief, total occlusion of 
the vessel to test the degree of its constriction (see later) 
(Fig. I). Approximately 25% to 30% of the left ventricular 
myocardium was thus supplied by the compromised left 
anterior descending artery (22). 
Three pairs of ultrasonic crystals (diameter I.5 to 2 mm), 
oriented in the short axis of :he heart, were placed in the left 
ventricular subenducardium: 1) in the apical region of the 
heart in the territory supplied by the left anterior descending 
coronary artery (LAD ares); 2) in the basal region of the left 
ventricular anterior wall supplied by the left circumflex ESMOLOL HEMQOILUTION 
coronary artery (LCA area); and 3) in the posterior left 9 - 
ventricular wall midway between the base and apex (LCP 
area) (Fig. 1). The LCA area was separated from the LV-AFT LV-AFT 
L, 
potentially ischemic LAD territory by at least I to 2 cm and 
supplied by the noncompromised circumflex coronary ar- 
E 
tery. Furthermore, no ischemic changes were noted in the 
LCA area during brief (IO s) mml occlnsions of the left 
anterior descending artery during the imposition of the 
critical left anterior descending artery stenosis. Thus. the 
LCA area was not a border zone of LAD area ischemia. 
The regional myocardial contraction pattern was assessed by 
continuously measuring the segment length between the Two 0 60 120 180 240 
sonomicrometer crystals, based on rhe measurement of Time [ min] 
ultrasound transit time (Soncmicrometer; model 120. Tri!on 
Technologies) (23.24). Tfie correct placement of the left 
anterior descending anery crystal, within the area of isch- 
emia was confirmed by observing regional function during a 
brief left anterior descending artery occlusion. The occur- 
rence of an ischemic contraction pattern not only confirmed 
proper crystal placement in Le LAD area but also the 
absence of significant collateralization (251. No LCA or LCP 
area dysfunction was observed during these occlusions. 
confirming that these regions represented normal, nonisch- 
emit left ventricular regions. 
Experimental protocol. Baseline measurcmenrs were re- 
corded at a pacing rate of 90 beatsimin. A critical constric- 
tion of the lefl anterior descending artery was then imposed 
at the same pacing rate by slowly tightening a micrometer- 
controlled snare to the point where the hyperemic response 
to a IO-s total leit anterior descending artery occlusion was 
totally abolished, yet no dysfunction occurred in the LAD 
area (26). With the critical consll.ction stable for 30 min, a 
second set of measurements (critical constriction) was re- 
corded at a pacing rate of 90 beats/min. 
.- _~ 
infusion, the response to acute left ventricular aRer!o:.di-g 
was recorded. The left ventricle was acutely afterloaded by 
constrictinc the descendinpl thoracic aorta for 6 heartbeats 
The response IO acute left ventricular afterloading and 
pacing tachycardia was assessed in 14 dogs with and without 
asmolol at each dog’s individual baseline hemoglobin level 
and with hemodilution-induced mild LAD area contractile 
dysfunction. Esmolol was administered as a Ioading infusion 
(500 &kg per min for I min), followed by a maintenance 
infusion rate of IM) uelke ner min. Afirr 2ll mia of esmolol 
Figure 2. Experimenlal protocol. After imposing a critical constric- 
tion 03 on the left anterior descending coronary artery. acute lefi 
vernricular afterloading ILV-#II MS performed by occluding the 
descending thwack aorta. After a recovery period of IO min. a 
pacing pertad ensued during which the pacing rare was increased in 
steps of IO boUrnin every 5 min. The I& venrricular afterloading 
and wacinx ceriod were wrfonned in random sauence aith and 
with&t e&&al. Hetnod&Aon was then pcrforrn~d (from 12.5 + 
0.3 g/IO0 ml In 7.4 i 0.4 g0W ml) until mildconWaclile d!4wtion 
in the area wpplied by the IeR rmWrior dencendieg arlery WN 
observed. The IeR ventricular afterloading and pacing peri& vith 
and wilhoul csmolol (randomized sequence) were lhen repeated at 
the hcmudilution stage (far defaila see Methodsl. bpm = beats psr 
mnwte 
until mild hemcdihnion-induced LAD area contractile dys- 
function occurred, as evidenced by a hemodilution-induced 
decrease in systolic shortening in the LAD area by >lS% 
from critical constriction. With this degree of hemodilution, 
left ventricular tierloading and the pacing protocol with and 
without tsmolol were -peated (Fig. 2). Global cnrdiovascn- 
lar and regional myocardial data were collected during a 10-s 
period of apnea. 
infusion rate was doubled in intervals of3 min, starting with 
0.05 &kg per min, until the heart rate was increased by 
>I0 beaislmin. Because the increase in heart rate due to 
In si,. additional animals, identically instrumented (with 
critic?! left anterior descending artery stenosis, but without 
atrial pacing). the degree of beta-blockade achieved with the 
esmolol regimen described was tested with isoproterenol. 
lsooroterenol was administered as a constant infusion. The 
during a brief period of ipea. AR:r a IO-min recovery 
period, the pacing rate was increased in steps of 10 beatsimin 
to a maximal rate of 140 beats/min, in 5-min imervals (2 1,271. 
The esmolol infusion was discontinued, and a 30min wash- 
out period ensured that no residual esmolol effect was 
present (28). The sequence of esmolol and nonesmolcl 
parinds was randomized. The animals then underwent he- 
mudilution by simultaneous exchange of blood with 6% 
dextran 70 (in 0.9% sodium chloride) (Abbott Laboratories) 
rfi achieve a stable left ventricular end-diastolic pressure of 
5 to 8 mm Hg. Normovolemic hemodi!ution was continued 
isoproterenol infusion was variable among dogs (range 10 to 
65 beatsimin), the ratio between the increase in heart rate 
and the isoproterenol infusion rate was used to assess 
beta.adrencrgic receptor responsiveness with and without 
esmoloi. thus providing an estimate of the degree of heta- 
adrenergic blockade achieved with the esmolol infusion 
regimen used in the present study. 
Data processing and calculations. The pressure signals 
were amplified by a low noise direct current preamplifier 
(Grass Instruments). digitally converted (analog-digital con- 
verter. model 16AF, McrraByre Corporation) and recorded 
with a personal computer (model 386, Compaq, Computer 
Corporation) at a sampling rate of 5M) Hz over 6 s during a 
briefperiod of apnea. 
Stroke volume was obtained as the product of the per- 
fused cross-sectional area of the aortic flow probe and the 
systolic aortic blood flow velocity-time integral; cardiac 
output was computed as the product of stroke volume and 
heart rate. Coronary perfusion pressure was calculated as 
the difference between diastolic pressure measured in the 
aorti: root and left ventricular end-diastolic pressure. Left 
ventricular dP/dt, the first derivative of left ventricular 
pressure with respect to time, was determined as the inspan- 
taneous slope of the left ventricular pressure-time curve. 
End-diastole was &fined by the first consistent positive 
deflection of left ventricular dF’/di. and end-systole by the 
abrupt cessation of forward blood Row in the aortic root. 
indicating aottic valve closure. 
Derived cardiovascular variables were computed accord- 
ing to standard formulas, Systemic vascular resistance 
(SVR) [dynes~s~cm-5J was computed as: 
SVR = MAP. &llCO, 
where YAP = mean arterial pressure (mm Hg) and CO = 
cardiac oatpot (liters/mitt) (29). 
The end-diastolic segment length and end-systolic length 
were determined using the preceding definitions for end- 
diastcle and end-systole. Systolic shortening (SS) and 
postsystolic shortening (PSS) were calculated as (9): 
SS = [(EDL - LminS)iEDL] . 100 
PSS = [(LminS - LminDMEDL - LminDJI’ IW, 
where EDL = end-diastolic segmenr length, LminS = min. 
imal length during systole, and LminD = minimal length 
during early diastole. For subsequent statistical analyses, 
negative values for postsystolic shortening were listed as 
zero (30). 
Statistics. Data at increasing pacing rates wore compared 
bv means of a reDca!ed measures multivariate analysis of 
v&iance with complete block design treating pacing iare as 
the repeated measure (SAS, PROC GLM, version 6.04, SAS 
Institute). Class variables were dog (to reduce interindivid- 
ual variability), esmolol (with and without), hemoglobin 
level (baseline hemoglobin and with hemodilution) and pac- 
ing rate: in addition, the interaction terms-pacing rate*; 
esmolol, pacing rate*hemoglobin level, esmolol*hemoglobin 
leve! and pacing ratecesmolol*hemoglobin level-were 
tested for statistical significance (p c 0.05). No individual 
comparison tests between various pacing rates and different 
experimenta.l conditions were performed. We resorted to 
using pacing rate as a class variable rather than as a 
continuous variable because we (21) previously found a 
nonlinear response of systolic shortening in the LAD area 
and of some global cardiovascular function variables to 
increasing pacing rates in dogs with and without critical teft 
anterior descending artery stenosis. 
A sign$cmr clavs vnrinble (for example. pacing rate) 
indicates that the specific variable under consideration sig- 
nificantly varies at different pacing rates when averaged over 
all esmolol and hemoglobin levels. A significant pacing 
rate*esmolol interaction term indicates that the response of 
a certam variable 10 increasing pacing rates is different with 
and without esmolol when averaged over all hemoglobin 
levels. A significant esmcJol*hemoglobin level interaction 
indicates that the response of a variable to esmolol at the 
baseline hemoglobin level is different from that with hemodi- 
lution when averaged over all pacing rates. A significant 
pacing rate*hemoglobin level interaction indicates that 
the response of a variable to increasing pacing rates at 
the native hemoglobin level is different to hemodilution 
when averaged over all esmalol levels. A significant pacing 
rateresmolol*hemoglobio level three-way interaction indi- 
cates that the response of a specific variable to increasing 
pacing rates is different depending on both esmolol and 
hemoglobin levels. In addition to comparing raw values, 
systolic shortening was also expressed as a percent of 
systolic shortening at a pacing rate of 9u beats/min (SS%90), 
and postsystolic shortening was also expressed as the differ- 
ence in postsystolic shortening and the pastsystolic shorten- 
ing present at a pacing rate of 40 beatsimin (PSSA9D). To 
determine whether the three left ventricular areas (LAD, 
LCA, LCP) would respond differently to increasing pacing 
rates, the differences in SS%9U and PSSA90 among these left 
ventricular areas were computed, arid statistical compari- 
sons were made by multivariate analysis of variance. using 
the model described. 
Six dogs did not recover from the pacing protocol a1 the 
baseline hemoglobin level, that is, systolic shortening in the 
LAD area remained severely depressed 10 0% ID 20% of 
systolic sMening at critical constriction even after the 
pacing rate was reduced to 90 beats/min and postsystolic 
shortening remained significant after the pacing protocol at a 
pacing rate of 90 beatbmin, and thus two different statistical 
analyses were performed. One analysis was performed with 
those eight dons in which a full set of data could be recorded 
(at the baseline hemoglobin level and with hemodilution); in 
a second analysis, all dogs were included but only Ihe 
baseline hemoglobin level was examined. Both analyses 
gave identical results, and the results are based on the eight 
dogs (n = 8) lhat completed the entire protocol both at the 
baseline hemoglobin level and with hemodilotion. Paired 
I tests were used to compare global cardiovascular and 
regional cardiac function between baseline and critical con- 
striction. 
Responses to acute left ventricular aflerloading ‘were 
assessed by comparing six consecutive hrartbeuts, starting 
with the last nonafterloaded beat (beat O), followed by live 
afterloaded beats. Statistically, this was done by means of a 
repeated measures multivariate analysis of vaiance with 
complete block design, treating the sequence of tierloaded 
heartbeats as the repeated measure (PROC GLM, SAS 
version 6.04. SAS Institute). Class variables were dog, 
esmolol, hemoglobin level and afterloading; in addition. 
the interaction terms: esmolol*afterloading. afterloading* 
hemoglobin level and afterloading*esmolol*hemoglobin 
level were tested for statistical signihcance tp < 0.05). As rn 
the analysis of the pacing data, sys:o!ic shortening was also 
expressed as percent of systolic shortening of the preafter- 
loading beat (SS%O). and postsystolic she-tening was also 
expressed as the difference in postsystolic shortening and 
the postsystolic shortening present at the preafterloading 
beat (PSSAO). To determine whether the three left ventricu- 
lar areas (LAD, LCA. LCFJ would respond differently to 
abrupt left ventricular afterloading. the difference in SS%R 
and PSSAO between these left venlricular areas compuled, 
and statistically compared by multivariate analysis of vari- 
ance using the model described earlier. The following results 
are again based on those eight dogs that completed the entire 
protocol at both hemoglobin levels. 
Data are presented as mean value 5 SEM. To avoid 
confusion in the figures and tables, ottlp significance symboks 
indicating p c 0.05 were placed, even when the actual 
p value was much less than 0.05. 
l&dine versus critical conslriclion (Table 1). Critical left 
anterior descending artery constriction decreased left ante- 
rior descendinR artery Row by approximately 2S%. Left 
0.3 mm Hg, concomitant with a decrease in end-diastolic 
lengths in the LAD and LCA areas. Systemic vascular 
resistance increased with crilicai letl anterior descending 
artery conntr;:tion. Except for these small but statistically 
significant changes, global cardiovascular and regional myo- 
cardial function were unchanged. 
Fhyskdagk esmalal ktu-bluekade. The ratio between iu- 
crease in heart rate and isoproterenol infusion rate with 
esmulol(21.2 + 5.6 beats/pg per kg) was significantly lower 
(p c 0.01) than without esmolol (139.7 t 41.7 beatsipg 
per kg). 
Fueiug pmtocol. act of increasing paring We. In- 
creasing the oacina rate sienificantlv influenced Rlohal car- 
diastolic pressure, cardiac output and mean left anterior 
descending artery Row were similar with hemodiIutian and in 
the baseline hemoglobin state (Fig. SA and 6, A and B). 
Mean arterial and coronary perfusion pressures and positive 
and negative maximal left ventricular dPldt were decreased 
with hemcdilutRm WiR. 4. A aud B and SB1. 
diovasc&u funct&, and with the exception of p&systolic Pacing rote*&& interaction. None of the observed 
shortening in the LCP area, the measured regional myocar- global cardiovascular or regiouat myucacdial function vari- 
dial contraction variables were also siguiticantly altered by ables demonstrated a significant pacing rate*esmold iuter- 
increasing the pacing rate (Fig. 3 to 6). action, indicating that the response of all observed variables 
Eflec? of esntolol. Esmolol infusion significantly de- to increasing pacing rates was unuffected by the presence 01 
creased maximal poshive left ventricular dP/dt (Fig. 3A). absence of earnold when averaged over hemoglobin levels. 
Systolic shortening in the LAD and LCA areas (Fig. 4, A and Pacing rawhemoglobin level interaction. No significant 
CI. and maximal neaattive left vechicnlac dP/dt IFis. 3B) oacine. rate*hcmotiobin level interaction was found in &%al 
tended to be lower with esmolol, yet this decrease id noi 
reach statistical significance (0.05 c p 4 0. I). 
Eficr o~kemodiluriun. The animals underwent hemodi- 
k&vascular fuktion variables. This indicates that the 
ssponse of globrl cardiovascular function to increasing 
pacing rates was siailar at the baseline hemoglobin level and 
lutiou from a baseline arterial hemoglobin level of 12.5 -C with hcmodilut:on in the pruscocs and absence of ermolol. 
0.3 g/l00 ml to 7.4 f 0.4 dl~+l ml, inducing moderate The only excepthn was Ieh ventricular end-diastolic pres- 
regional contractile dysfunction in the coronary Row- sure (Fig. 5B). This pressure decreased at the baseline 
compromised LAD area (Fig. 4A1. Left veutricular end- hemoglobin level with increasing pacing rates, and o111y with 
Pacing ra!e [ bpm ] 
Figure 3. Response to increasing pacinp rates with I& 0) nnd 
without (*. 0) csmolol (IM) &zz per min) al the baseline (II.5 2 
0.3 gilKI ml) hemoglobin level (dctxd symbols) and with hemcdilu- 
rion (1.4 f 0.4 gilW ml) (open symbd$). A, Maximal w.i~ive LV 
dPldt (first derivative of left ventricular pressured. B. Maximal 
negative (min) LV dP/dt. + = signilicanr (p < 0.05) pacing rate 
effwt; * = significant (p I 0.05) hemodilulion effect; + = sigoili- 
cant (p < 0.05) esmalol effect. bpm = beats per IIIIRU~C. 
the h&best pacing rate investigated (140 beatstmin) did it 
slightly increase. With hemcdilution. left ventricular end- 
diastolic pressure remained constant with pacing rates up to 
120 beatsimin and increased with further increases in pacing 
rate. Regional myocardial function demonstrated signiti- 
candy different responses to increasing pacing rates with 
hemodilution as compared wilh the native hemoglobin state. 
Systolic shortening (Pig. 4) and end-diastolic length [Fig, 7) 
in all three left ventricular areas responded di5erently to 
increasing pacing rates at the baseline hemoglobin level as 
compared with the hemodilution stage. In rhe LAD and LCA 
areas. this interaction was manifested by a more exaggerated 
decrzdse in systolic shorkning that started at lower pacing 
rates than at the baseline hemoglobin level (Pig. 4. A and Bl: 
systolic shortening in the LCP area was relatively constant 
with increasing pacing rates at the baseltie hemoglobin level 
but increased slightly with increasing pacing r&s with 
hemodilution (Fig. 40. There was an insienificant nacinc . _ 
rafe*hemoalobinievel in!eraction in postsykc shortening 
in all three left ventricular areas (Fig. 6;. 
Pacing uale*esmolol~hemoylobin level inkvocrion. 
None of the observed global cardiovascular or regional 
myocardial function variables demonstrated a significant 
Figure A S)slolic shortening in response 10 increasing pciw tales 
with U. 01 and without (0,O) esmolel WI &a per mini at the 
baseline (12.5 i 0.3 gflW ml) hemoglobin level (ckd sylabdr) and 
with hemodilution (7.4 + 0.4gIl00ml) (apmsymbob). A, tnthe area 
supplied by the (SS LAD). B, In the basal aqect of me anterior left 
wnrricular wall supplied by the left circumflex artery (SS LCA]). C, 
In the paslerior lei3 veatriculst wall supplied by the IeR circtunlkx 
artery (SS LCP). * = signiiicanl (p < O.US) pacing rdte effect: * = 
significant (p 4 0.05) hemcdilulion effect; T = significant (p C 0.05) 
hemcdilution+p&n~ rate interaction, indicating that the response to 
increasing pacing rates al Ihe baseline hem&bin level is differenl 
from that with hemcdilutian, bpm - beats per minute; EDL = 
end-diastolic Isnah. 
pacing rate*e~molol*hemoglobin level three-way inlerac. 
lion. 
Di$ertnces in rhe response o$ various left venrricular 
areas ro increasing pacing rate. The relative decrease III 
systolic shortening due tu increaing pacing rates was mwe 
exaggerated in the LADarea than inthe LCA and LCP areas 
(Fig. 9). The relative decrease in systolic shortening ob- 
served in the LCA area was significantly different from the 
response of systolic shortening in the LCP area IFig. 90. 
With higher pacing rates, systolic shortening was better 
preserved in Ihe LCA area at cbe baseline hcmogiobin level: 
wi!h hemodilurion, systolic shortening exhibited a steady 
decrease in the LCA area with increasing pacing rates, 
whereas systolic shartcninp. remained constant in the LCP 
area. With increasinp u&w rates. postsyatolic shorkning 
increased to a great&-extent in the-LAD area than in th; 
LCA area (Fig. 8). .;rere was no difference between izc;crease 
B/A , , , , ,,, , 
100 
1-----&- 
)B 
20, ) , I , 
90 100 110 120 130 140 
Pa&g rate [ bpm ] 
Figure 5. Response lo increasing pacio~ rates wilh Im. 01 and 
withou 0, 0) esmolol (100 &kg per tnin~ at the native (12.5 + 
0.3 gilW ml) hemoglobin level (c&rd sjmbolr) and with hemodilu- 
tion (7.4 c 0.4 gilOa ml) (open rylo&). A, Left ventricular 
end-diastolic pressarc ILVEDP). 8, Mean rrteriat pressure (MAP). 
l = rignificiutt (p i 0.05) pacing rate effect: * = significant (p < 
0.05) hemodilution &xl; 7 = significant (p i 0.05) hemo- 
dilution*pacing rate interaction. indicating that the response to 
increasing pacing rates at the baseline hemoglobin level is ditTerent 
from that with hcmodilution. bpm = beats per miautc. 
in postsystolic shortening in the LAD and LCP areas with 
increasing pa&g rates. 
Alterloading protocol. A similar increase in mean arterial 
pressure was observed with descending thoracic aoriic con- 
striction al the native hemoglobin level and with hemodilu- 
tion. The increase in mean arterial pressure was idrniical 
with and without esmolal (baseline hemoglobin, no esmoiol 
72.3 * 4.X38.3 + 5.5 mm Hg [before lefl ventricular after- 
loading/fifth afterloaded beat]; baseline hemoglobin with 
esmotol 72.0 % 4.7184.0 f 7.1 mm Hg; hemodilution, no 
esmolol 57.0 2 2.7172.3 + 4.5 mm Hg: hemodilution, with 
esmoIol55.4 + l&73.2 * 2.6 mm Hg). 
Eflecr ofdmpr fefi venwiculor ojbrlooding. Abrupt left 
ventricular afterloading significantly influenced all global 
cardiovascular function variables. Mean arterial and core- 
nary perfusion pressures a well as coronary Row (+ZS%) 
increased considerably because of wute IeR ventricular 
afterloading; maximal positive and maximal negative MI 
ventricular dP/dt increased sligbU~, whereas stroke v&me 
decreased (data not shown). Systolic shortening decreased 
signiicantly in ail left ventricuku areas studied (Fig. IO). 
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wchuut (N Oi c<molol(1W &ki & &a] at the baseline (12.5 f 
0.3 ~KNI ml) hemoglobin level (rlarrd spnbaols) and witb bemodilu- 
lion (7.1 2 0.4 g!KKI ml) (apea symbais). A, Cardiac output (CO). 
B, Mean coronary Row (MCFI in the &I anterior descending artery. 
+ = significant Ip < 0.05) pacing rate effect. bpm = beats per 
minute: I = liters. 
However. costsvstolic sbortenbxz increased only in the 
coronary flow-compromised LADarea; postsystoic short- 
ening in the LCA and LCP areas was not a&ted by acute 
left ventricular afterloading (Fig, I I). 
E&et oftsmolol. Esmolol did not significantly influence 
global cardiovascular and regional myocardial function vari- 
ables with acute left ver&ular afterloading. 
Effect of hemodilrtrion. Mean arterial and coronary per- 
fusion presstxres and maximal positive and negative I& 
ventricular dP/dt were decreased with hemodilution (data 
not shown). Stmke volume was significantly increased as 
compared with the baseLine hemoglobin level (data not 
shown). Rerional contractile dvsfm&on in the LAD area 
was manifested by a decrease-in systolic shortening (Fig. 
IOA) in conjunction with an increase in postsystolic short- 
ening (Fig. 1 i A). 
EsmoloMierloadim interaction. The onlv siinilicant 
esmolol-afte&adinz in&-action was observei in-the re- 
sponse of postsyst&c shortening in the LAD area to acute 
left ventricular afterkxdiag (Fig. IIA). With esmolol, 
postsystolic shortening due to acute left ventricular after- 
loading wag lnore exaggerated than without esma\ol (Fig. 
I IA). In orher regions of left ventricular myocardium, as 
well as in all global cardiovascular function variables, the 
1; 
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Figure 1. End-diastolic segment length response lo increasing pac- 
ing rates with (M. 0) and without 0, 01 esmolal (100 &kg per min) 
at the baseline (12.5 ? 0.3 gllW ml) hemoglobin level lclmed 
symbols) and with hemodilution (7.4 * 0.4g/lCQ ml) kqwn symbols). 
A, In the area supplied by the left anterior descending artery (EDL 
LAD). 6, In the basal aspect of the anterior left ventricular wall 
supplied by the left circumflex artery (EDL WA). C, In the 
posterior left ventricular wall supplied by the left circumkx artery 
(EDL LCP). + = significant (p c 0.05) pacing rate efkct; * = 
significant (p < 0.05) hemodilution efkct: V = si~silicant (p < 0.05) 
hcmadilution*pasing we interaction, indicaring that the response lo 
increasing pacing rates at the baseline hemogloain Level is different 
from that with hemodilution. bpm = beats p?r minute. 
esmclol*afterloading interaction was insignificant, indicating 
that the response to acute left ventricular afterloading was 
not affected by the presence or absence of esmolol. 
Afrerloadirig*h@moglohh level inreracrion. A significant 
afterloading*hemoglobin level interaction was found only in 
the resnonse of uostsvstalic shonenina in the LAD area (Fia. 
I IA) aid in the’ resp&z of systolic shortening in the LCP 
area (Fig. IOU, indicating that the decrease in systolic 
shortening in the LCP area and the increase in postsystolic 
shortening in the apical anterior myocardium due to acute 
left ventricular afterloading was more exaggerated with 
hemodilution than at the baseline (high) hemoglobin level. 
Afterl6ndina*esmolol*hemoalobin level inferaction. 
None of the observed dobal cardiovascular or reeional 
myocardial function van’ables demonstrated a significant 
afterlaading*esmolol*hemoglobin Level interaction. 
Differences irr the nspponse of various lefr ven:ricular 
rmas lo acufe left ventricular a&hding. The relative 
decrease in systolic shortening due to acute left ventricular 
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Flgure 8. Postsystolic shortening response to increasing pleing 
rates with (m. 0) and without (*, 0) esmolol Ml0 &kg per min) at 
the baseline (12.5 + lJ.3 g!llXl ml) hemoglobin level (deed symbol) 
and with hemodiluiion (7.4 + 0.4 gJl00 ml) (open symbcW. A, la the 
area supplied by the left anterior descending artery (PSS LAD). 
8, In the basal aspect of the anterior left ventricular wall supplied by 
the IeR circumflex artery (PSS LCA). C, In the posterior left 
ventricular wall supplied by the left circumRcx artery (PSS LCP). 
l = significant (p C 0.05) pacing rate etfecl: * = significant (p < 
0.05) hemodilution effecr. bpm = beats per minute; TS = total 
segmental shortening. 
afterloading was more exaggerated in the LAD area than in 
the LCA area [Fig. 12B). The decrease in systolic shortening 
was greater in the LCP area than in the LCA area (Fig. IX). 
The increase in p&systolic shortening due to acute left 
ventricular afterloading was greater in the apical anterior 
myocardium than in the LCA area (Fig. I I). No significant 
interregional differences were found between the response of 
postsystolic shortening in the LCA and LCP areas. 
Discussion 
The results of the present study demonstrate that es- 
molol, at an infusion rate of 100 @kg per min. does not 
provide intrinsic cardioprotective properties for myocar- 
dium supplied by a critically constricted coronary artery. 
Esmolol does not influence the development of regional 
myocardial contractile dysfunction with increasing heart 
rates in apical coronary flow-compromised left ventricular 
myocardium with normal baseline function. It also does not 
protect the coronary flow-compromised left ventricular 
Figure 9. Diierences in the response of sysrohc shortening in lhe 
three left ventricular areas owine to increasing pacins rates. nomml- 
imd 10 systolic shortening at a-pacing rate Gff‘so b&tslmin (bpm). 
with (a, 0) and without (0.0) esmolol (IO0 pglkg per mini al the 
baseline (12.5 t 0.3 gNJO ml) hemoglobin level (cicwd symbols) and 
with hemodilution 0.4 f OldlWml) (opeasymb&). A, Difference 
between the posterior left ventricular wall supplied by the left 
circumtlex artery (LCP) and the area supplied by the left anterior 
descending (LAD) artery (ASS@0 LCP-LAD). 8, Difference be- 
tween thebasal aspect of the anterior left ventricular wall supplied 
by the Ion circumflex artery (LCAI and the LAD arca (ASSpY 
LCA-LAD). C, DiUerence between the LCP and Ihe LCA areas 
(A.SSp!M LCP-LCA). + = significant Ip < 0.05) pacing rate eftecl; 
* = significant (p < 0.05) hemodiluiion &cl: 7 = significant (p < 
0.051 hemodilulion-uacine rate interaclion. indicating that the re- 
sponse to increa&Fa&g rates at the basc!inc hew&bin level is 
different from that with hemodihuion. bpm = bears per minute. 
myocardhnn with hemodilution-induced moderate contrac- 
tile dysfunction from exaggerating myocardial contractile 
dysfunction due to increasing heart rates. These findings do 
not invalidate esmolol’s proved ability to decrease an ele- 
vated heart rate or to prevent iachycardia in response to 
particularly stressful stimuli. However, the present findings 
indicate that thcro may be little cardioprotective effect 
provided by esmolol beyond control of heart rate. 
Esmcdol dwage @men. The esmolol dosage regimen of 
the present study was similar to the one used in wvious 
studies demonstrating a beneficial effect of esmolol on isch- 
emit myocardium (4,6.10), and this regimen is also similar to 
esmolo~ doses that are clinically effective in preventing 
tachycardia in response to laryngoscopy and endotracheal 
intubation (31,321. The amount of beta-blockade achieved 
Figure IO. Systolic shortening response Io acute left venlricular 
(LV)anerloadingwithf~, O)and wirhout(O.01 esmolol(lMJpgkg 
per min) at the bareline (12.5 f 0.3 d1133 m!) hemoglobin level 
(closed sp~bols~ and with hemodilution (7.4 + 0.4 ~1CQ ml) (open 
symbols). A. In the area supplied by the left anterior descending 
artery (SS LAD). B, In the basal aspec( of the anleriw left 
venrricular wall supplied by the left circwnkx very (SS LCA). 
C, In the posterior wall supplied by the 1.4 circumflex coronw~ 
artery ISS LCPI. + = sigoifiFant (p < 0.05) afterloading effect; * = 
significant (p < 0.05) hemodilution effect; V = significant (p < 0.05) 
hemadilutiolraRcrlaading interaction. indicating that the response 
to acute left ventricular aftedaading at the baseline hemoglobin level 
is different from that with hemodilution. EDL = end-diastolic 
length. 
with this esmolol dose, resulting in a sevenfoid shift in the 
isoproterenol doseheart rate response curve. is equivalent 
to an approximately 7oL70 beta-receptor blockade (6.28,33). 
Despite this obvious beta-adrenergic receptor blockade, 
global cardiovascular and regional myocardialfunction were 
mostly unchanged. The only variable signiCcantly depressed 
by esmolol MY maximal positive left ventricular dP/& 
indicating beta,-antagonism: no signs ofbe@-blockade were 
observed. This finding is in keeping with a previous report 
that esmolol (100 &kg per min) depresses maximal posilive 
left ventricular dP/dt but does not affect regional myocardial 
function (IO). The esmolol dosage regimen, the achieved 
degree of 70% beta-adrenergic receptor blockade and the 
observed esmolol-induced changes in global cardiovascular 
and regional myocardial function were thus similar in the 
present study as in those previous reports in which cardio- 
protective properties of esmolol were observed. 
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Figure Ii. Postsystolic shortening response to acute kR ventricular 
(LV) afterlanding with [m, 0) and without (0.0) esmolol (IW p@g 
per min) at the baseline (12.5 f 0.3 gilo0 ml) hemoglobin level 
klosed symbols) and with hemodilulion 0.4 2 0.4 g/l00 ml) (open 
symbols). A, B and C as in Figure 8. + = significant (p < 0.05) 
afterloading effect: t = significant (p < MIS) hemodilution e&cl: 
V = significant (P < 0.05) hemodilution*afrcrloadinn interaction. 
indicat& that th; response to acute left ventricular abloading ai 
the baseline hemoglobin level is dilferent from that with hemodilu- 
lion; t = significant (p < O.OS) esmoloktfterloading interaction, 
indicating that the response to acute left ventricular afterloading is 
different with or without esmolol. 
Differences from previous studies. Significant differences 
exist between the present study and previous investigations, 
which demonstrated cardioprotective effects of esmolol dur- 
ing regional myocardial ischemia (4,6,101, First, myocardial 
&hernia was induced by total coronary occlusion in previ- 
ous investigations; whereas in the present study a critical 
constriclion was imposed on the left anterior descending 
artery. Second, barbiturate anesthesia was used in the 
former studies, which results in hyperdynamic baseline 
cardiac functional stale; whereas in the present study, a 
complete anesthetic-analgesic technique with halothane 
(0.9% end-tidal), supplemented with fentanyl 0.3 &kg Per 
min was used. Finally, heart rate was controlled in the 
present study; whereas in the former investigations, heart 
rate was considerably lower (by approximately 20 to 40 
beatslmin) during esmolol infusions (4.6.10). 
Coronary occiuslon Versus critical coronary constriction. 
Coronary occlusion decreases myocardial blood flow by 75% 
to 90% in the central ischemic zcme (1,2,4,10.34). r.nd by 
012345 
68dl8 durlq LV afterloading 
F&we 12. Differences in the resoonse of systolic shonenina in the 
three left ventricularareas due t&acute left~entricular afterl&ding, 
normalized to systolic shortening observed at the last preafterload- 
ingbeat, with(M. q )and without~O.O)esmolol(100llglkgpermin) 
at the basetine (12.5 f 0.3 e/lW ml) hemoalobin level Nosed 
symbds)and with hemcdiltttio~(7.4 + 0.4glltiml) (qua sy&&). 
A, Difference between the pusterior left ventricular wall supplied by 
the left circumflex artery {LCf) and the area supplied by the left 
anterior descending (LAD) artery (ASS%0 LCP-LAD). 8, Ditkr- 
ence between the basal aspect of the anterior left vetttricul~ wall 
supplied by ihe left circumflex artery (LCA) and the LAD area 
(ASS%0 LCA-LAD). C, Difference between the LCP and the LCA 
areas (ASS?&0 LCP-LCA). + = significant (p i 0.05) afterloading 
effect; * = rigniiicanl (p < 0.05) hemodilulian e&cl; V = signifi- 
cant (p i 0.05) hemodiludon+aftcrloading interaction, indicating 
that the response toacutc Ml ventricular aftedoadingat the baseline 
hemoglobin level is different fmm that with hemodiludon. 
approximately 40% to 75% in the horder zone of ischcmia 
(2,4,34). In contrast, mean left anterior descending artery 
flow in the present study decreased by approximately 25% 
with critical constriction (Table 1). Although no direct com- 
parison between epicardial coronary blood flow measured 
with a Doppler Bow zeter and myocardial blood flow 
determined by micmsphtres cao he made, thesedata suggest 
that the flow impediment induced by critical coronary con- 
striction is less severe than the flow restriction achieved with 
coronary occlusion tech1 iques. Whereas a coronary occltt- 
sion directly jeopardizes the viability of centd zone isch- 
emit myocardium (4,6,34), the critical coronary constriction 
only deprives the myocardium of most of its coronary flow 
reserves, such that adaptation to functional states associated 
with an elevated myocardial oxygen demand is impaired and 
regional ischemic myocardial contractile dysfunction results 
coronary artery bypass surgery (44); tachycardia always 
(21,3S-38). In the present study. this regional ischemic 
accompanied ischemic events during noncardiac surgery in 
myocardial contractile dysfunction was manifested as an 
mild!‘; hypertensive patients (12): treatment of ‘achycardia 
imuroved final outcome in natients sufferine from acute 
exaggerated decrease in systolic shortening and the devel- 
opmcttt ofear!y diaMic dysfunction. in the form ofpostsy+ 
tolic shortening, with increasing pacing rates in the anterior 
apicat myocardium supplied by the left anterior descending 
artery (Fig. 4. 8 and 9). We were unable to demonstrate 
intrinsic cardiopmtecthe effectiveness of esmolol. that is. a 
beneficial effect provided by esmolol beyond control of heart 
rate: however. one relxtrt found that low dose csmolol 
(50 ,udkg per mitt) did &~ce infarct size in a canine model 
of 60 min of left anterior descending artery occlusion despite 
similar heart rates in the esmolol-lreated and the control 
animals (6). The possibility therefore remains that the etTcct 
of esmolol on the function of coronary Row-compromised 
myocardium may dither from that in preserving the viability 
of infarctine mvocardium. 
Type of tttieslhesia. Because of the vagolytic effccrs oi 
barbiturates (39). hyperdynamic baseline cardiac function i, 
usually observed in dogs anesthetized solcly with barbitu- 
rates, as evidenced in previous studies I4.101 by elevated 
heart rates. mean arterial pressures and maximal left ven- 
tricular dP/dt, as compared with values in conscious dogs at 
rest (2,39,40). Such a hyperdynamic and tachycardiac state 
is particularly deleterious for ischemic myocardium because 
not only is myocatdial oxygen consumption elevated (41) but 
also subendocardial myocardial blood flow is compromised 
(42.43). Because this hyperdyttamic and tachycardic state 
was sustained throughout coronary occlusion and reperfu- 
sion in control dogs not treated with esmolol (4.10), the 
outcome variables infarct size (4) and regional myocardial 
contractile function (IO) may have been deleteriously intlu- 
ettced in these control dogs. To prevent deleterious hyper- 
dynamic and tachycardiac responses to surgery, we used 
halothane O.% end-tidal anesthesia (1 MAC equivalent) (20) 
in the present study. A continuous infusion of fentanyl 
(0.3 &kg per min) was added not only to decrease the sinus 
rate fo ~90 beatslmin but also to depress the frequency of 
secondary pacemaker centers below this limit. as we have 
previously observed that such secondary pacemaker centers 
often became active with frequencies well above 90 beats/ 
min after mechanical crushing of :he sinus node (211. The 
halothane-fentanyl anesthesia technique thus enabted inves- 
tigation of the response of global cardiovascular and regional 
myocardial function to increasing pacmg rates beginning at a 
rate similar to the physiologic baseline heart rdte of con- 
scious dogs at rest (X39,40). 
Control of heart rate. Control of heart rate, particularly 
prevention of tachycardia, is of prime importance in opti- 
mizing myocardial function and outcome in clinical as well 
as experimental conditions of compromised coronary blood 
Row. Tachycardia was the only hemodynamic variable sig- 
nificantly associated with the occurrence of new lschemic 
episodesin patients with coronary artery disease undergoing 
myocardlal mfarction (7); tachycardia as late as 14 h after 
e!pstimen?ally induced myocardial infarction may increase 
infarct size slgntficandy (45) and nitroglycerin may worsen 
ischcmia in patients s&ring from acute myocardial iofarc- 
rioo when fach Jcardia occurs during nitroglycerin treatment 
146). These findings suggest hat the decrease in heart rate as 
such observed in esmolal-treated animals may explain the 
favorable outcome in esmolol-treated animals (4,101. This 
interpretation is in keeping with the results of the present 
study m wi-nch no beneficial esmolol e&t was found in 
terms of regional myocardial function when heart rate was 
cootrolled between Ihe two experimenta) groups with and 
without esmolol. 
Aftcrlaading. By consrricting the descendmg chora& 
aorta. acute lefi ventricular afterloading depressed regional 
myocardial function in all left ven:ricular areas investigated 
m the present study (Fig. IO); however, only in rhe LAD area 
(rhe anterior apical myocardium) did significant early dia- 
stolic dysfunction develop, manifested as significant 
poslsysrolic shortening (Fig. II). The relatively mild de- 
crease in systolic shortening during acute leti ventricular 
afterloading in the LAD area may be explained in part by a 
concomi&nl rise in ttansstenotic left anterior descending 
artery flow by approximately 25%. As during pacing-induced 
tachycardia. esmolol failed to aiter the response of global 
cardiovascular and regional myl%ardial contractile function 
lo acute left ventricular afterloajing; in contrast, there was 
significantly more early diastolic dysfunction during con- 
striction of the descending thoracic aorta with ermolol as 
was observed without esmolol in the hemodilution stage 
(Fig. IIA). The findings with left ventricular afterloading 
therefore confirm our conclusion that esmolol lacks intrinsic 
cardioproteclive effects. Because of the lack of longitudinal 
segmental shortening infomtation. we cannot rule out an 
effect of csmolol on configuralional changes during the 
different stress conditions investigated in the present study. 
A previous study using a similar model, however, noted 
changes in segment shortening in the iongitudinal axis that 
were qualitatively similar to changes in short-axis segment 
shortening during graded ischemia and acute ieft ventiicnlx 
aftertoading ir. the left anterior descending artery-supplied 
left ventricular apical myocardium 147). 
Statistics-power anrdysysb. The main finding of the 
present study, that csmolol lacks intrinsic cardioprotective 
effects. is based on the analysis of eight dogs in which 
complete data were recorded at both baseline hemoglobin 
level and during hemodilution: the same conclusion is 
reached when analyzing all anirr,ais in = 14) but restricting 
the analysis to observations at the baseline hemoglobin 
level. Two analyses were performed to determine the power 
of this conclusion. In the first analyais, we considered two 
monotonically separated responses of systolic shortening in 
the coronary flow-compromised LAD area to increasing 
pacing rates, with a 20% (relative) di5erence in systolic 
shortening be&veer: the pacing periods with 8.nd without 
esmolol as physiologically significant (9,Zl). At a type I error 
of 0.05, the power of the present study to de:.ect such a 
physinlngically siz&icant difference is 0.81. A second power 
analysis revealed that X0 animals would be necessary to 
make the observed difference between the responses of 
systolic shortening in the flow-compromised LAD area to 
increasing pacing rates with and without esmolol statisti- 
cally, yet not necessarily physiologically significant (at a 
type I errOr of 0.05 and a type II error of 0.80). Our finding 
that esmdol lacks intrinsic cardioprotective properties 
therefore does not result from an insufficient number of 
observations but from the fact that there is no physiologi- 
cally sigmficaat di5crence in the response of global cardio- 
vascular and regional myocardial function to increasing 
oacine: rates with and without esmolol. 
Cr&ai constriction. Critical left anterior descending ar- 
tery constriction resulted in a slight but statistically signifi- 
cant decrease in left ventricular end-diastolic pressure and 
end-diastolic lengths in the LAD and LCA areas (Table I). 
There is no obvious explanation for these findings; adrener- 
gic activation and a minimal volume !oss are possible, but 
speculative, mechanisms. These small changes occurred 
before the actual pacing and afterloading protocol and thus 
should not compromise the significance of our findings XI 
coronary artery disease. The degree of left anterior descend- 
ing artery constriction used in the present study was aimed 
at blunting the physiologic hyperemic response lo a IO-s total 
left anterior descending artery occlusion and thus to deprive 
the LAD area from its coronary flow reserves without 
inducing myocardial ischemia with corresponding contrac- 
tile dysfunction at the baseline hemoglobin level. Ischemic 
regional contractile dysfunction was induced only by he- 
modilution in addition to the critical left anterior descending 
artery stenosis. 
Summary. The influence of esmolol (100 &kg per min) 
on the response of global cardiovascular and regional myo- 
cardial co&act&z function to pacing-induced lachycardia, 
isovolemic hemodilution and acule left ventricular afterload- 
ing was investigated in an actii* canine model of critical left 
anterior descending artery constrlctiun. The results indicate 
that esmolol does not alter the response to increasing pacing 
rates or acute left ventricular afterloading in the present 
model in which preload, afterload and heart rate were 
controlled. At an infusion rate of 100 &kg per min, esmolol 
therefore lacks intrinsic cardioprotective properties, that is, 
it does not have effects beneficial for coronary flow- 
compromised myocardium beyond control of heart rate. 
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